Hexarelin 5mg
Studied for growth-axis and performance research.
Hexarelin is a potent hexapeptide GHRP (growth-hormone-releasing peptide) studied for its strong GH-release profile and cardiovascular-research applications. It is one of the more potent members of the GHRP family on a per-mg basis.
Proposed mechanism
Hexarelin is a ghrelin-receptor agonist driving pulsatile GH release. Additionally, research describes direct cardiomyocyte effects — binding sites in cardiac tissue independent of the GH-release pathway.
Research highlights
- Potent GHRP hexapeptide
- Direct cardiac tissue binding reported in research
- Short half-life supporting pulsed protocols
- Used in GH-research and cardiovascular-model studies
Research protocol notes
Reconstitute under sterile technique with bacteriostatic water. Typical volumes range from 1–3 mL depending on the target working concentration. Swirl gently — do not shake — to avoid peptide shearing.
Stacking and comparative studies
Sometimes combined with GHRH analogs (CJC-1295, Tesamorelin) in dual-pathway GH research.
Handling and storage
Lyophilized powder is stable at ambient shipping temperatures. Once reconstituted with bacteriostatic water, store at 2–8 °C and use within 28 days. For long-term storage of unreconstituted vials, freeze at −20 °C and protect from light.
Frequently asked
How does hexarelin differ from GHRP-2 and GHRP-6?
More potent per-mg, with reportedly direct cardiac effects that GHRP-2 and -6 do not share to the same degree.
What about cortisol/prolactin impact?
Less selective than ipamorelin — hexarelin research reports meaningful cortisol and prolactin elevation at higher research doses.
Is it still used in current research?
Yes — particularly in cardiovascular-model research leveraging its direct cardiac-tissue activity.
What is the typical half-life?
Short — under an hour in research models.
